💙😇

Dear everyone 😍 If you love charts that help you challenge your way of thinking and better understand history and markets, why not take a look at our macro cycles? Done by Europe‘s #1 Technical Analyst 9 years running. @arvyMacroCycles

cartalax does what BPC-157 and KPV JUST CAN'T DO - and there's actual human evidence behind it BPC-157 works by building blood vessels into injured tissue. that's why it's so good for tendons, ligaments and joints. BUT deep cartilage barely has any blood supply to build into. that's the unbridgable gap. cartalax is three amino acids (AED), made in russia as a bioregulator for cartilage and connective tissue in cell work it pushes chondrocytes, your cartilage cells, to grow, and lowers p53 so they stay alive instead of dying off. and the "no human data" on cartalax was wrong. it was just in russian. slugina et al., 2015: elderly patients, jaw surgery, cartalax used around the operation. the authors followed bone regeneration clinically and on x-ray, and concluded it worked in older age groups. so there's the human BONE data. now let’s think about what it could actually do; cartilage is the most annoying tissue of the body. no blood vessels, no nerves, and chondrocytes that barely divide. that’s why a worn knee can't just heal itself with time. there’s no blood supply to bring in the right repairing agents. BPC-157 leans hard on angiogenesis. it builds vessels into damaged tissue... but again, deep cartilage has nothing to build into. KPV can’t fill that gap either. it shuts off NF-κB and calms the cytokines that chew through cartilage matrix (IL-1β, TNF-α), but it never tells a chondrocyte to live or make new matrix. cartalax goes after the cell itself. in cell studies it pushes chondrocytes to grow and lowers p53, the signal that sends them toward dying off. the theory is simple: keep the few cartilage cells you have alive and dividing. where that could matter: worn knees and early osteoarthritis, where chondrocyte loss is the whole story. spinal discs, which are also avascular and degrade with age. spinal osteochondrosis is one of the things the russian institute positions it for. aging bone, since the jaw data shows regeneration moving in old patients. recovery around joint surgery, which is another use they position it for. & this is where the stack clicks together. KPV puts out the inflammation. BPC rebuilds the soft tissue around the joint. cartalax tells the cartilage cells to stay alive. three layers of the same joint, zero overlap. is it proven for cartilage in humans? no... these days, fucking NOTHING good is. but the mechanism is aimed at exactly the tissue the other two can’t reach, and that’s what makes it worth watching. not medical advice. Slugina et al. 2015, Kubanskii Nauchnyi Meditsinskii Vestnik (DOAJ)

THE DOT COM BUBBLE VERSUS THE “AI BUBBLE” VISUALIZED: